Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Employer
-
Field
-
expertise in high-performance computing, artificial intelligence, and data ecosystems, creating an interdisciplinary innovation environment for research, development, start-ups, and industrial projects. AI:AT
-
, which means: • Developing a third-party funded project to be submitted to a competitive programme (e.g. Marie Curie, FWF individual project, FWF Esprit) • Further developing your academic profile
-
administration and organisation. We are looking for a/an Coordinator 174 Research Services and Career Development Job vacancy starting: undefined.(MM-DD-YYYY).undefined | Working hours: 40,00 | Classification
-
hours: 30,00 | Classification CBA: §48 VwGr. B1 Grundstufe (praedoc) Limited contract until: 31.08.2029 Job ID: 4246 Are you passionate about developing and applying cutting-edge AI-assisted proteomic
-
students. In addition to providing a solid academic education, we also place a special emphasis on the personal development of students. We support students in developing curiosity and critical thinking
-
actively contribute to this strategic initiative by researching and developing scalable, practical frameworks for implementing Trustworthy AI principles in diverse projects and across multiple technology
-
while ensuring highest ethical standards. What You’ll Do: Lead the development and execution of the affiliate medical plan for Switzerland and Austria. Establish and enhance the scientific reputation
-
question and its significance, (2) the context, (3) the methods, (4) originality and anticipated contribution to the literature, and (5) alignment with the ERC project. While there is flexibility to develop
-
emerging to address the ‘broken system’ of antibiotic R&D. It focuses on the actors and stakeholders seeking to develop a radically altered antimicrobial innovation ecosystem by establishing alternative
-
biomedical research field is emerging to address the ‘broken system’ of antibiotic R&D. It focuses on the actors and stakeholders seeking to develop a radically altered antimicrobial innovation ecosystem by